Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 1;214 Suppl 2(Suppl 2):S51-7.
doi: 10.1093/infdis/jiw287.

Cytokines and T-Cell Homeostasis in HIV Infection

Michael L Freeman  1 , Carey L Shive  2 , Thao P Nguyen  1 , Souheil-Antoine Younes  1 , Soumya Panigrahi  1 , Michael M Lederman  1
Affiliations
Review

Cytokines and T-Cell Homeostasis in HIV Infection

Michael L Freeman et al. J Infect Dis. .

Abstract

Untreated human immunodeficiency virus (HIV) infection is characterized by progressive CD4(+) T-cell depletion and CD8(+) T-cell expansion, and CD4(+) T-cell depletion is linked directly to the risk for opportunistic infections and infection-associated mortality. With suppression of HIV replication by antiretroviral therapy, circulating CD4(+) Tcell numbers typically improve while CD8(+) T-cell expansion persists, and both CD4(+) T-cell cytopenia and CD8(+) T-cell expansion are associated with morbidity and mortality. In this brief review, we report on the role that selected homeostatic and inflammatory cytokines may play both in the failure of CD4(+) T-cell restoration and the CD8(+) T-cell expansion that characterize HIV infection.

Keywords: HIV; T cells; cytokines.

PubMed Disclaimer

References

    1. Stacey AR, Norris PJ, Qin L et al. . Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83:3719–33. - PMC - PubMed
    1. Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003; 21:265–304. - PubMed
    1. Funderburg NT, Andrade A, Chan ES et al. . Dynamics of immune reconstitution and activation markers in HIV+ treatment-naive patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine. PLoS One 2013; 8:e83514. - PMC - PubMed
    1. Ofotokun I, Na LH, Landovitz RJ et al. . Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257. Clin Infect Dis 2015; 60:1842–51. - PMC - PubMed
    1. Kelesidis T, Tran TT, Stein JH et al. . Changes in inflammation and immune activation with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy: ACTG 5260s. Clin Infect Dis 2015; 61:651–60. - PMC - PubMed